Furthermore, Supplee and collaborators compared G360 panel with the ctDx-Lung panel (Resolution Bioscience, Redmond, Washington, USA), spanning exons and some introns of 20 NSCLC-associated genes, in 16 patients known to harbor an ALK, ROS1 or RET fusion. Here, ALK is linked to non-small cell lung carcinoma.